The agenda for the 25 June 2014 Transparency Commission meeting is now available.  The Commission will examine the following health care technologies:

• Zoster virus vaccine (Zostavax) - new vaccine
• Alprostadil (Vitaros) - new formulation
• Certolizumab pegol (Cimzia) - new indication

For more details, go to: http://www.has-sante.fr/portail/upload/docs/application/pdf/2014-06/odj_ct_25062014_internet.pdf